SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63392 357 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
61124Never mind. I see that Davidoff anticipated my question and answered it. Thankjargonweary-9/16/2022
61123So the 20% interest payment to you is applied to what valuation?jargonweary-9/16/2022
61122Yes, you can loan your stock to shorts and it very easy to turn off, or in the cDavidoff-9/16/2022
61121Schwab sent me an e-mail yesterday asking to set up loaning the SAVA shares fromerickerickson-9/16/2022
61120Schwab loan rate on SAVA now 20.5 %.sysiphus-9/16/2022
61119At $4.20 in June, I said the stock would probably double upon FDA acceptance of ghettogoulash19/15/2022
61118wild swing in price on 4X volume in IBRX...can't find anything on the net??urslor-9/15/2022
61117That's an easy one. Just look at the rest of the market. It has so much compOlecranon-9/14/2022
61116A better question is what was it doing at $2-3?ghettogoulash-9/14/2022
61115IBRX has been a tear the last several days on no obvious news. Any ideas why?Olecranon19/14/2022
61114Remi B. had an interesting comment at the end of the HC Wainwright conference yeghettogoulash-9/14/2022
61113IBRX finally hit my cost average today, after a lot of averaging down. But I nevghettogoulash-9/14/2022
61112Sarepta Therapeutics Announces Proposed Offering of $1.0 Billion of Convertible erickerickson19/12/2022
61111At a cursory glance, that blood test looks very promising, but it has nothing toghettogoulash-9/11/2022
61110SavaDX....Remi don't worry about it !! Just like when Zevalin was approved scorman1-9/10/2022
61109Hope Everyone is Doing Well. Been Awhile. Anyone have any opinions on NAUT? Lgonnahappensoon-9/9/2022
61108SAVA loan now 19% from Schwab and stock pps up $3.19. This is fun.sysiphus19/9/2022
61107Before the buyout of IMMU, I remember Allatwwk fully endorsing this course of acghettogoulash-9/9/2022
61106SAVA just hit 76.7% at iborrowdesk.com. Started the day at 63.1% . (The data comghettogoulash-9/8/2022
61105Unless others are aware of information I haven’t seen, AUPH’s SP has been slowlyOlecranon39/8/2022
61104AMLX doing well today.plhky3465-9/8/2022
61103Interest rate at Schwab for loaned SAVA shares just went to 18.5%. A friend saidsysiphus19/7/2022
61102SRPT: Sarepta Therapeutics Announces That FDA has Lifted its Clinical Hold on Serickerickson-9/6/2022
61101GILEAD finance.yahoo.comurslor99/4/2022
61100Yep, saw that in the FAQ.erickerickson-9/3/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News